Beyond CD8+ T cells, in colon cancer and lung carcinoma models, NR4A1 inhibition has been shown to decrease the suppressive function of Tregs through the reduced expression of CD25 and cytotoxic T-lymphocyte-associated antigen 4 (CTLA4). Here, CTLA4 is linked to malignant colon neoplasm.